Cargando…
Alendronate, a double-edged sword acting in the mevalonate pathway
Aminobisphosphonate aledronate is a compound commonly used clinically for the treatment of osteoporosis and other bone diseases, as a result of it preventing bone resorption. However, in previous years it has also been used to obtain cellular and animal models of a rare genetic disorder termed Meval...
Autores principales: | TRICARICO, PAOLA MAURA, GIRARDELLI, MARTINA, KLEINER, GIULIO, KNOWLES, ALESSANDRA, VALENCIC, ERICA, CROVELLA, SERGIO, MARCUZZI, ANNALISA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526081/ https://www.ncbi.nlm.nih.gov/pubmed/26096667 http://dx.doi.org/10.3892/mmr.2015.3957 |
Ejemplares similares
-
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds
por: Tricarico, Paola Maura, et al.
Publicado: (2014) -
Mevalonate kinase deficiency and IBD: shared genetic background
por: Bianco, Anna Monica, et al.
Publicado: (2014) -
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis
por: Tricarico, Paola Maura, et al.
Publicado: (2013) -
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study
por: Tricarico, Paola Maura, et al.
Publicado: (2013) -
Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link
por: Tricarico, Paola Maura, et al.
Publicado: (2015)